J&J Shares At New Session High, Up 2.2%; FDA Has Approved Co., Amgen’s Dexamethasone For Multiple Myeloma; Amgen Shares Quiet

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.